Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cameroni

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Il Farmaco; Edizione Pratica|August 1, 1982
Correlations between diffusion rate constant, partition coefficient and biological activity of substituted benzoic acidsM T Bernabei, F Forni, G Coppi, et al.
Il Farmaco; Edizione Pratica|May 1, 1981
[Soap chromatography in the separation and identification of amines, aminophenols and phenols used as hair dyes]M T Bernabei, V Ferioli, G Gamberini, et al.
Die Pharmazie|December 1, 1991
The effect of the cross-linking time period upon the drug release and the dynamic swelling of gelatin microspheresM A Vandelli, F Forni, G Coppi, et al.
Bollettino Chimico Farmaceutico|January 1, 1983
[Release of polymorphic forms of progesterone from dimethylpolysiloxane matrices]M T Bernabei, G Gamberini, V Ferioli, et al.
Bollettino Chimico Farmaceutico|July 1, 1982
[Crystalline form of progesterone in silicone elastomers]M T Bernabei, G Gamberini, V Ferioli, et al.
Il Farmaco; Edizione Pratica|October 1, 1978
Polymorphism of chloramphenicol stearate. II - Kinetics of solid-state transition of crystal formsR Cameroni, M T Bernabei, F Forni, et al.
Journal De Pharmacie De Belgique|November 1, 1991
The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheresM A Vandelli, F Forni, V Iannuccelli, et al.
Il Farmaco; Edizione Pratica|December 1, 1973
[Polymorphism of progesterone. I. Preparation and characterization of polymorphic forms]R Cameroni, G Gamberini, M T Bernabei, et al.
Il Farmaco; Edizione Scientifica|July 1, 1976
[Heteropolycyclic systems. V. 4-alkyl-2,3,3a,4-tetrahydro-1H-pyrro1/2,1-c/ /1,2,4/benzothiadiazin-5,5-dioxide and their bz-substituted derivatives]M T Bernabei, R Cameroni, G Gamberini, et al.
Il Farmaco; Edizione Pratica|March 1, 1977
[Polymorphism of ethylbiscumacetate]R Cameroni, G Gamberini, V Ferioli, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Il Farmaco; Edizione Pratica|August 1, 1982
Correlations between diffusion rate constant, partition coefficient and biological activity of substituted benzoic acidsM T Bernabei, F Forni, G Coppi, et al.
Il Farmaco; Edizione Pratica|May 1, 1981
[Soap chromatography in the separation and identification of amines, aminophenols and phenols used as hair dyes]M T Bernabei, V Ferioli, G Gamberini, et al.
Die Pharmazie|December 1, 1991
The effect of the cross-linking time period upon the drug release and the dynamic swelling of gelatin microspheresM A Vandelli, F Forni, G Coppi, et al.
Bollettino Chimico Farmaceutico|January 1, 1983
[Release of polymorphic forms of progesterone from dimethylpolysiloxane matrices]M T Bernabei, G Gamberini, V Ferioli, et al.
Bollettino Chimico Farmaceutico|July 1, 1982
[Crystalline form of progesterone in silicone elastomers]M T Bernabei, G Gamberini, V Ferioli, et al.
Il Farmaco; Edizione Pratica|October 1, 1978
Polymorphism of chloramphenicol stearate. II - Kinetics of solid-state transition of crystal formsR Cameroni, M T Bernabei, F Forni, et al.
Journal De Pharmacie De Belgique|November 1, 1991
The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheresM A Vandelli, F Forni, V Iannuccelli, et al.
Il Farmaco; Edizione Pratica|December 1, 1973
[Polymorphism of progesterone. I. Preparation and characterization of polymorphic forms]R Cameroni, G Gamberini, M T Bernabei, et al.
Il Farmaco; Edizione Scientifica|July 1, 1976
[Heteropolycyclic systems. V. 4-alkyl-2,3,3a,4-tetrahydro-1H-pyrro1/2,1-c/ /1,2,4/benzothiadiazin-5,5-dioxide and their bz-substituted derivatives]M T Bernabei, R Cameroni, G Gamberini, et al.
Il Farmaco; Edizione Pratica|March 1, 1977
[Polymorphism of ethylbiscumacetate]R Cameroni, G Gamberini, V Ferioli, et al.
Pageof 5